These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 38073554

  • 1. Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.
    Boldt D, Busse L, Chawla LS, Flannery AH, Khanna A, Neyra JA, Palmer P, Wilson J, Yessayan L.
    Ren Fail; 2023; 45(2):2290932. PubMed ID: 38073554
    [Abstract] [Full Text] [Related]

  • 2. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, Forni L, Lawrence RF, MacEwen C, Ostermann M, Mouncey PR, Harrison DA, Rowan KM, Young JD, Watkinson PJ.
    Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y.
    Cochrane Database Syst Rev; 2020 Dec 14; 12(12):CD012467. PubMed ID: 33314078
    [Abstract] [Full Text] [Related]

  • 6. Advances in continuous renal replacement therapy: citrate anticoagulation update.
    Tolwani A, Wille KM.
    Blood Purif; 2012 Dec 14; 34(2):88-93. PubMed ID: 23095407
    [Abstract] [Full Text] [Related]

  • 7. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG, de Albuquerque CCC, Assis CF, Rodrigues BCD, E Siqueira Campos BP, de Oliveira Valle E, Cabrera CPS, de Oliveira Gois J, Segura GC, Strufaldi FL, Mainardes LC, Ribeiro RG, Via Reque Cortes DDP, Lutf LG, de Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Rodrigues CE.
    Trials; 2020 Nov 11; 21(1):920. PubMed ID: 33176886
    [Abstract] [Full Text] [Related]

  • 8. Renal replacement therapy and anticoagulation.
    Brandenburger T, Dimski T, Slowinski T, Kindgen-Milles D.
    Best Pract Res Clin Anaesthesiol; 2017 Sep 11; 31(3):387-401. PubMed ID: 29248145
    [Abstract] [Full Text] [Related]

  • 9. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun 11; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 10. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct 11; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 11. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, Mülling N, Mehrländer M, Rosenberger P, Marx G, Simon TP, Jaschinski U, Deetjen P, Putensen C, Schewe JC, Kluge S, Jarczak D, Slowinski T, Bodenstein M, Meybohm P, Wirtz S, Moerer O, Kortgen A, Simon P, Bagshaw SM, Kellum JA, Meersch M, RICH Investigators and the Sepnet Trial Group.
    JAMA; 2020 Oct 27; 324(16):1629-1639. PubMed ID: 33095849
    [Abstract] [Full Text] [Related]

  • 12. [Advances in the application of regional citrate anticoagulation for continuous renal replacement therapy in patients with liver failure].
    Ning QQ, Meng QH, Zhu YK.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul 20; 26(7):549-552. PubMed ID: 30317782
    [Abstract] [Full Text] [Related]

  • 13. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019.
    Deep A, Alexander EC, Khatri A, Kumari N, Sudheendhra K, Patel P, Joarder A, Elghuwael I.
    Pediatr Crit Care Med; 2024 Jan 01; 25(1):15-23. PubMed ID: 38169336
    [Abstract] [Full Text] [Related]

  • 14. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C, Lin T, Zhang J, Liang H, Di Y, Li N, Gao J, Wang W, Liu S, Wang Z, Jiang H, Liu C.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug 01; 30(8):777-782. PubMed ID: 30220281
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Zhou Z, Liu C, Yang Y, Wang F, Zhang L, Fu P.
    Crit Care; 2023 Jun 07; 27(1):222. PubMed ID: 37287084
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H, Tsujimoto Y, Nakata Y, Fujii T, Takahashi S, Akazawa M, Kataoka Y.
    Cochrane Database Syst Rev; 2020 Mar 13; 3(3):CD012467. PubMed ID: 32164041
    [Abstract] [Full Text] [Related]

  • 17. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr 13; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 18. [A survey of regional citrate anticoagulation for emergency continuous renal replacement therapy].
    Cui Q, Sun F, Liu S, Xu J, Zhu H, Yu X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May 13; 32(5):595-600. PubMed ID: 32576354
    [Abstract] [Full Text] [Related]

  • 19. Nafamostat mesylate versus regional citrate anticoagulation for continuous renal replacement therapy in patients at high risk of bleeding: a retrospective single-center study.
    Liu D, Zhao J, Xia H, Dong S, Yan S, Zhuang Y, Chen Y, Peng H.
    Eur J Med Res; 2024 Jan 20; 29(1):72. PubMed ID: 38245802
    [Abstract] [Full Text] [Related]

  • 20. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH.
    Nephron Clin Pract; 2004 Jan 20; 97(4):c131-6. PubMed ID: 15331942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.